A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Prognostic Role of Porphyromonas gingivalis Gingipain Rgp and Matrix Metalloproteinase 9 in Oropharyngeal Squamous Cell Carcinoma




TekijätKylmä Anna Kaisa, Sorsa Timo, Jouhi Lauri, Mustonen Harri K, Mohamed Hesham, Randén-Brady Reija, Mäkitie Antti, Atula Timo, Hagström Jaana, Haglund Caj

KustantajaInternational Institute of Anticancer Research

Julkaisuvuosi2022

JournalAnticancer Research

Tietokannassa oleva lehden nimiAnticancer research

Lehden akronyymiAnticancer Res

Vuosikerta42

Numero11

Aloitussivu5415

Lopetussivu5430

ISSN0250-7005

eISSN1791-7530

DOIhttps://doi.org/10.21873/anticanres.16046

Verkko-osoitehttps://ar.iiarjournals.org/content/42/11/5415

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/177261669


Tiivistelmä

BACKGROUND / AIM

The oral bacteria involved in the development of periodontitis alter the tissue conditions and modify immune responses in a way that may also influence tumor development. We investigated the prevalence of R gingipain (Rgp), a key virulence factor of the oral pathobiont Porphyromonas gingivalis, and the tissue-destructive enzymes matrix metalloproteinase 8 (MMP-8) and 9 (MMP-9) in 202 unselected consecutive oropharyngeal squamous cell carcinoma (OPSCC) samples. We further investigated the relationships between these factors and human papillomavirus (HPV) status, Treponema denticola chymotrypsin-like proteinase (Td-CTLP) immunoexpression, clinical parameters, and patient outcome.

PATIENTS AND METHODS

Clinicopathological data were derived from university hospital records. Rgp, MMP-8, and MMP-9 immunoexpression was evaluated by immunohistochemistry; the immunohistochemistry of Td-CTLP and HPV has been described earlier for this patient series. Cox regression analysis including death by causes other than OPSCC as a competing risk served to assess sub distribution hazard ratios.

RESULTS

In multivariable survival analysis, positive tumoral MMP-9 immunoexpression predicted poor prognosis among all patients [sub distribution hazard ratio (SHR)=2.4; confidence interval (CI)=1.2-4.4, p=0.008], and especially among those with HPV-negative OPSCC (SHR=3.5; CI=1.7-7.3, p=0.001). Positive immunoexpression of Rgp in inflammatory cells was associated with favorable outcome among all patients (SHR=0.5, CI=0.2-0.9, p=0.021) and among those with HPV-negative disease (SHR=0.4, CI=0.2-0.9, p=0.022).

CONCLUSION

Our results suggest that tumoral MMP-9 may be related to poor outcome in OPSCC, especially in HPV-negative disease, while Rgp immunoexpression in inflammatory cells is associated here with better disease-specific survival (DSS).


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 22:54